A Canadian gold project developer and a U.S. bank holding company both received analyst upgrades, one of which has an implied upside of nearly 50%.
Company Name | Exchange | Ticker | Last Price | Market Cap | Recommendation | Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
---|---|---|---|---|---|---|---|---|---|
Major Drilling Group International Inc | TSX | MDI | 5.53 | 443.2 | Upgrade to buy from hold | Michael Mills | Beacon Securities Ltd | 7.00 | 26.6% |
Morneau Shepell Inc | TSX | MSI | 15.95 | 765.5 | Upgrade to sector outperform from sector perform | Stephanie Price | CIBC World Markets | 19.00 | 19.1% |
Veresen Inc | TSX | VSN | 16.29 | 4,616.0 | Upgrade to buy from hold | Robert Catellier | GMP | 19.00 | 16.6% |
Aptose Biosciences Inc | TSX | APS | 7.90 | 92.1 | Initiate with outperform | Christopher N Marai Phd | Oppenheimer & Co | 19.51 | 147.0% |
Penn West Petroleum Ltd | TSX | PWT | 2.98 | 1,482.0 | Downgrade to sell from hold | Kristopher Zack | Desjardins Securities | 3.00 | 0.7% |
Beacon Securities Ltd upgraded Major Drilling Group International Inc (TSX: MDI), engaged in the business of contract drilling, to buy from hold with a price target of C$7.00, indicating an upside of 26.6% from current levels.
Morneau Shepell Inc (TSX: MSI), engaged in providing human resource consulting and outsourcing services, was upgraded by CIBC World Markets to sector outperform from sector perform with a price target of C$19.00, indicating an upside potential of 19.1% from current levels.
GMP upgraded Veresen Inc (TSX: VSN), engaged in the business of owning and operating energy infrastructure assets across North America, to buy from hold with a price target of C$19.00, indicating an upside of 16.6% from current levels.
Coverage on Aptose Biosciences Inc (TSX: APS), engaged in the development of cancer therapies, was initiated with an outperform rating at Oppenheimer & Co, assigning a 12-month price target of C$19.51, indicating an upside potential of 147.0% from current levels.
Desjardins Securities downgraded Penn West Petroleum Ltd (TSX: PWT), engaged in the business of exploring oil and natural gas, to sell from hold by reducing its price target to C$3.00 from C$7.50, indicating an upside of 0.7% from current levels.
Company Name | Exchange | Ticker | Last Price | Market Cap | Recommendation | Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
---|---|---|---|---|---|---|---|---|---|
Omega Healthcare Investors Inc | NYSE | OHI | 38.24 | 4,872.8 | Upgrade to buy from hold | Omotayo T Okusanya II | Jefferies | 43.00 | 12.4% |
American Eagle Outfitters Inc | NYSE | AEO | 12.27 | 2,386.4 | Upgrade to outperform from market perform | Anna Andreeva | Oppenheimer & Co | 14.00 | 14.1% |
SM Energy Co | NYSE | SM | 30.18 | 2,034.3 | Upgrade to outperform from neutral | Paul Grigel | Macquarie | 70.00 | 131.9% |
Gulfport Energy Corp | NASDAQ | GPOR | 37.83 | 3,235.7 | Initiate with buy | Daniel D Guffey | Stifel | 50.00 | 32.2% |
Emerald Oil Inc | NYSE | EOX | 1.37 | 91.3 | Downgrade to neutral from outperform | Paul Grigel | Macquarie | 4.00 | 192.0% |
Jefferies upgraded Omega Healthcare Investors Inc (NYSE: OHI), engaged in the business of making investments in and providing finance to the long-term care industry, to buy from hold by raising its price target to $43.00 from $39.00, indicating an upside of 12.4% from current levels.
American Eagle Outfitters Inc (NYSE: AEO), engaged in the business of retailing men’s and women’s casual apparel, footwear, outerwear and accessories, was upgraded by Oppenheimer & Co to outperform from market perform by raising its price target to $14.00 from $12.00, indicating an upside potential of 14.1% from current levels.
Macquarie upgraded SM Energy Co (NYSE: SM), engaged in the acquisition, exploration, development and production of crude oil, natural gas and natural gas liquids, to outperform from neutral with a price target of $70.00, indicating an upside of 131.9% from current levels.
Stifel initiated coverage on Gulfport Energy Corp (NASDAQ: GPOR), engaged in owning and operating oil and gas properties in the Louisiana Gulf Coast area of the U.S., with a buy rating assigning a 12-month price target of $50.00, indicating an upside of 32.2% from current levels.
Emerald Oil Inc (NYSE: EOX), engaged in the exploration and production of oil, was downgraded by Macquarie to neutral from outperform by reducing its price target to $4.00 from $7.00, implying an upside potential of 192.0% from current levels.